| Mr Michael Charles Desjardins, MSN, APRN | |
|
668 E 12225 S Ste 203, Draper, UT 84020-8385 | |
| (801) 572-8255 | |
| (801) 572-8144 |
| Full Name | Mr Michael Charles Desjardins |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 668 E 12225 S Ste 203, Draper, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801924766 | NPI | - | NPPES |
| 3777014408 | Other | UT | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 377701-4405 (Utah) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 377701-4405 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Charles Desjardins, MSN, APRN Po Box 1812, Draper, UT 84020-1812 Ph: (801) 518-9203 | Mr Michael Charles Desjardins, MSN, APRN 668 E 12225 S Ste 203, Draper, UT 84020-8385 Ph: (801) 572-8255 |
News Archive
Automated patient monitoring systems have been designed to reduce delays in diagnosis of sepsis in hospitalized patients.
On June 1, leaders of the health care industry reaffirmed their pledge to reform a health care system that is rife with inefficiencies, costs too much, and fails to deliver the quality of care Americans expect.
After a median follow-up of 5.1 years, among women with lymph node-positive early-stage breast cancer and a recurrence score of 25 or lower who received adjuvant endocrine therapy with or without chemotherapy, postmenopausal patients had no added benefit from chemotherapy, while premenopausal patients who received chemotherapy had improved invasive disease-free survival (IDFS) and an early indication of improved overall survival (OS), according to data from the SWOG S1007 RxPONDER clinical trial presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
Heart failure is a leading cause of death and hospitalisation and represents a major burden on health services. It is estimated that over 15 million people in Europe suffer from heart failure and the syndrome accounts for over 2% of national expenditure on health. The new guidelines on heart failure from the European Society of Cardiology are eagerly awaited.
Although many blame the health law for all recent health care cost increases, trends that bump up the cost of care were in place before the law was enacted and are being driven up even more by routine costs, some say.
› Verified 6 days ago